Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,034) with videos related to
Page
of 104
Sort By:
You have reached the last page of results.
This site can display upto 1,034 results.
Cell Host & Microbe
|
March 11, 2017
Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence
Jeanna A Bugaytsova, Oscar Björnham, Yevgen A Chernov, et al.
The Journal of Clinical Investigation
|
November 15, 2022
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
Rebecca A Drummond, Jigar V Desai, Amy P Hsu, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer
D Ranti, H Yu, Y A Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 104
Search research articles
Search
Showing results (1031-1040 of 1,034) with videos related to
Sort By:
Page
of 104
You have reached the last page of results.
This site can display upto 1,034 results.
Cell Host & Microbe
|
March 11, 2017
Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence
Jeanna A Bugaytsova, Oscar Björnham, Yevgen A Chernov, et al.
The Journal of Clinical Investigation
|
November 15, 2022
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
Rebecca A Drummond, Jigar V Desai, Amy P Hsu, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer
D Ranti, H Yu, Y A Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
P G Corrie, A Marshall, P D Nathan, et al.
Page
of 104